Approval · Notice of Compliance 23377 · 2020
PREVYMIS: Notice of Compliance 23377
Issued March 20, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23377
- Date
- March 20, 2020
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To seek approval for use of an in-line filter at the point of administration of Solution for Injection and for change in release and shelf-life specification of the drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREVYMIS | Not yet assigned | — |
Medicinal ingredients
- LETERMOVIR 240 MG per 12ML
- LETERMOVIR 480 MG per 24ML